Subtitle
Ultra-High Dose-Rate Proton FLASH Improves Tumor Control.
Subtitle
Ultra-High Dose-Rate Proton FLASH Improves Tumor Control.
Proto therapy Time
September 2023
Executive summary
This study reported that proton-FLASH (>60 Gy/s) was more effective in reducing tumor burden and decreasing tumor cell proliferation compared conventional proton irradiation (<0.05 Gy/s) based on a mouse model of NSCLC. Proton-FLASH was more efficient in increasing the infiltration of cytotoxic CD8+ T-lymphocytes inside the tumor while simultaneously reducing the percentage of immunosuppressive regulatory T-cells (Tregs) among T-lymphocytes.Â
Key content topics
Related contents
Proton Therapy Publication
October 2024
The Radiosurgery Society Working Groups on GRID, LATTICE, Microbeam, and FLASH Radiotherapies: 2022 - 2023 Advancements Symposium and Subsequent Progress Made.
Proton Therapy Publication
September 2024
The Potential and Challenges of Proton FLASH in Head and Neck Cancer Reirradiation.
Proton Therapy Publication
June 2024
Navigating the Critical Translational Questions for Implementing FLASH in the Clinic.
Proton Therapy Publication
March 2024
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.
Proton Therapy Publication
April 2024
FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?
Proton Therapy Publication
April 2024
Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer.
Webinar
April 25, 2024
Translating ConformalFLASH® from Research to Reality
Yohan
Godart
Michele
Kim
Jarrick
Nys